(CSL) Carlisle Companies - Overview
Sector: Industrials | Industry: Building Products & Equipment | Exchange: NYSE (USA) | Market Cap: 13.507m USD | Total Return: -9.9% in 12m
Avg Turnover: 123M
EPS Trend: 78.7%
Qual. Beats: 0
Rev. Trend: 29.9%
Qual. Beats: 0
Warnings
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
Carlisle Companies Incorporated (NYSE: CSL) is a manufacturer specializing in building envelope products and solutions for commercial and residential markets. The company operates through two primary segments: Carlisle Construction Materials (CCM), which focuses on single-ply roofing systems and insulation, and Carlisle Weatherproofing Technologies (CWT), which provides waterproofing, air/vapor barriers, and spray foam insulation.
The building envelope sector is highly sensitive to non-residential construction cycles and energy efficiency regulations, as these components are critical for a structures thermal performance. Carlisle utilizes a multi-brand strategy, distributing products under names such as Carlisle SynTec and Hunter Panels through a network of authorized applicators and distributors. Investors may find additional data on these operational segments at ValueRay.
Founded in 1917 and headquartered in Scottsdale, Arizona, the company has transitioned into a pure-play building products entity. This business model relies on high replacement demand in the commercial roofing sector, where maintenance and reroofing cycles provide a consistent revenue stream independent of new construction starts.
- Commercial roofing replacement cycle drives long term recurring revenue growth
- Raw material cost fluctuations for petrochemical products impact operating margins
- Non residential construction spending levels dictate demand for building envelope solutions
- Strategic pivot to pure play building products optimizes capital allocation efficiency
- Federal energy efficiency regulations increase adoption of high R value insulation systems
| Net Income: 725.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 1.52 > 1.0 |
| NWC/Revenue: 28.76% < 20% (prev 18.76%; Δ 10.00% < -1%) |
| CFO/TA 0.18 > 3% & CFO 1.05b > Net Income 725.1m |
| Net Debt (2.21b) to EBITDA (1.21b): 1.82 < 3 |
| Current Ratio: 3.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.1m) vs 12m ago -8.05% < -2% |
| Gross Margin: 35.57% > 18% (prev 0.37%; Δ 3.52k% > 0.5%) |
| Asset Turnover: 86.99% > 50% (prev 91.78%; Δ -4.79% > 0%) |
| Interest Coverage Ratio: 11.05 > 6 (EBITDA TTM 1.21b / Interest Expense TTM 92.0m) |
| A: 0.24 (Total Current Assets 2.03b - Total Current Liabilities 601.3m) / Total Assets 5.99b |
| B: 1.24 (Retained Earnings 7.41b / Total Assets 5.99b) |
| C: 0.18 (EBIT TTM 1.02b / Avg Total Assets 5.72b) |
| D: 1.71 (Book Value of Equity 7.41b / Total Liabilities 4.34b) |
| Altman-Z'' = 8.59 = AAA |
| DSRI: 0.99 (Receivables 692.1m/699.4m, Revenue 4.98b/5.00b) |
| GMI: 1.05 (GM 35.57% / 37.47%) |
| AQI: 0.90 (AQ_t 0.52 / AQ_t-1 0.58) |
| SGI: 0.99 (Revenue 4.98b / 5.00b) |
| TATA: -0.05 (NI 725.1m - CFO 1.05b) / TA 5.99b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of May 30, 2026, the stock is trading at USD 344.81 with a total of 236,358 shares traded.
Over the past week, the price has changed by +3.75%,
over one month by -0.20%,
over three months by -12.36% and
over the past year by -9.87%.
Carlisle Companies has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CSL.
- StrongBuy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 410.1 | 18.9% |
P/E Trailing = 19.4977
P/E Forward = 15.949
P/S = 2.7144
P/B = 8.1704
P/EG = 1.0632
Revenue TTM = 4.98b USD
EBIT TTM = 1.02b USD
EBITDA TTM = 1.21b USD
Long Term Debt = 2.88b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.98b USD (from shortLongTermDebtTotal, last quarter) + Leases 100.5m
Net Debt = 2.21b USD (calculated: Debt 2.98b - CCE 771.3m)
Enterprise Value = 15.7b USD (13.5b + Debt 2.98b - CCE 771.3m)
Interest Coverage Ratio = 11.05 (Ebit TTM 1.02b / Interest Expense TTM 92.0m)
EV/FCF = 17.00x (Enterprise Value 15.7b / FCF TTM 924.8m)
FCF Yield = 5.88% (FCF TTM 924.8m / Enterprise Value 15.7b)
FCF Margin = 18.58% (FCF TTM 924.8m / Revenue TTM 4.98b)
Net Margin = 14.57% (Net Income TTM 725.1m / Revenue TTM 4.98b)
Gross Margin = 35.57% ((Revenue TTM 4.98b - Cost of Revenue TTM 3.21b) / Revenue TTM)
Gross Margin QoQ = 34.52% (prev 33.75%)
Tobins Q-Ratio = 2.62 (Enterprise Value 15.7b / Total Assets 5.99b)
Interest Expense / Debt = 3.08% (Interest Expense 92.0m / Debt 2.98b)
Taxrate = 21.75% (35.5m / 163.2m)
NOPAT = 795.6m (EBIT 1.02b * (1 - 21.75%))
Current Ratio = 3.38 (Total Current Assets 2.03b / Total Current Liabilities 601.3m)
Debt / Equity = 1.81 (Debt 2.98b / totalStockholderEquity, last quarter 1.65b)
Debt / EBITDA = 1.82 (Net Debt 2.21b / EBITDA 1.21b)
Debt / FCF = 2.39 (Net Debt 2.21b / FCF TTM 924.8m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.68% (Net Income 725.1m / Total Assets 5.99b)
RoE = 38.36% (Net Income TTM 725.1m / Total Stockholder Equity 1.89b)
RoCE = 21.30% (EBIT 1.02b / Capital Employed (Equity 1.89b + L.T.Debt 2.88b))
RoIC = 15.56% (NOPAT 795.6m / Invested Capital 5.11b)
WACC = 8.64% (E(13.5b)/V(16.5b) * Re(10.01%) + D(2.98b)/V(16.5b) * Rd(3.08%) * (1-Tc(0.22)))
Discount Rate = 10.01% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.56 | Cagr: -7.43%
[DCF] Terminal Value 77.05% ; FCFF base≈858.4m ; Y1≈984.0m ; Y5≈1.45b
[DCF] Fair Price = 458.2 (EV 20.8b - Net Debt 2.21b = Equity 18.5b / Shares 40.5m; r=8.64% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 78.74 | EPS CAGR: 7.12% | SUE: 0.62 | # QB: 0
Revenue Correlation: 29.87 | Revenue CAGR: 0.97% | SUE: -0.22 | # QB: 0
EPS current Quarter (2026-06-30): EPS=6.45 | Chg30d=-1.86% | Revisions=-17% | Analysts=9
EPS next Quarter (2026-09-30): EPS=6.41 | Chg30d=+3.13% | Revisions=+33% | Analysts=9
EPS current Year (2026-12-31): EPS=20.95 | Chg30d=+2.99% | Revisions=+45% | GrowthEPS=+8.0% | GrowthRev=+2.5%
EPS next Year (2027-12-31): EPS=23.45 | Chg30d=+1.66% | Revisions=+60% | GrowthEPS=+11.9% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: +60%